Case/UHC Center for AIDS Research
案例/UHC 艾滋病研究中心
基本信息
- 批准号:8093104
- 负责人:
- 金额:$ 12.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAfricaAntsAreaArtsAwardBioethicsBiological AssayBiometryCaringClinicClinicalClinical ResearchClinical Trials UnitCollaborationsCommunicationComprehensive Cancer CenterCore FacilityDatabasesDevelopmentDiseaseEducation and OutreachEpidemiologyEthicsFacultyFosteringFoundationsFundingFutureGene ExpressionHIVHealth PromotionHospitalsImmuneImmunologyImmunotherapyIndividualInfectionInstitutionInternationalInternational AIDSJointsKenyaLaboratoriesLawsLeadershipLinkMalignant NeoplasmsMedical ResearchMedical centerMedicineMolecular VirologyMycosesPathogenesisPatient CarePatientsPerformancePositioning AttributePreventionPrevention ResearchProviderReport (account)ResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResourcesSamplingSchoolsServicesSiteSpecimenThe science of MycologyTimeTrainingTraining SupportTraining and EducationTranslational ResearchTuberculosisUgandaUnited KingdomUnited StatesUnited States National Institutes of HealthUniversitiesUniversity HospitalsVaccinesWorkbasechemotherapydesignepidemiology studyexperienceforgingglobal healthimmune functioninstrumentationinterestmedical schoolsmeetingsmembernoveloutreachprogramsrepositoryrestorationskin disordersuccessuser-friendlyvolunteerworking group
项目摘要
The CWRU/UHC CFAR has established a unique research program with key strengths in intemational research, ITuberculosis, clinical/translational research and in training. A 16 year close collaboration between CWRU and Makerere
IUniversity in Uganda has a fostered an effective HIV research infrastructure in Kampala. An effective Fogarty AIDS pntemational Training and Research Program (AIRTP) with at least 30 degree graduates now working in Africa has also
promoted an enhanced level of HIV research, HIV care and prevention in Uganda. In Cleveland and Uganda, through the Tuberculosis Research Unit, key studies of epidemiology, pathogenesis and therapy for this leading co-morbid infection
late also undertaken by the CFAR. CWRU investigators also are leading novel NCI-sponsored trials of chemotherapy fow
I/kiDS-related malignancy in Uganda and Kenya. The CWRU/UHC CFAR has also developed one of the most productive
Iclinicalcores in the CFAR network that has supported more than 120 separate clinical and translational research projects
Idudng this period of award because of its unique and patient-care/research data base, a linked specimen repository an_
seamless access to patient volunteers and clinical samples
rrhe CFAR leadership (Steering Committee) that comprises both the Core Directors and leaders of 7 scientific working groups assures that scientific needs and directions of the Center are coordinated with service needs and resources. Six
CFAR service cores are each designed to provide CWRU investigators with user-friendly access to state of the art services and facilities both in Cleveland and in Kampala. These cores: Uganda Laboratory, Clinical, Biosafety, Immune Function, Epidemiology/Biostatistics and the new Molecular Virology and Gene Expression are led by expedenced investigators and provide quality services that include on-site training and range from access to instrumentation for experienced users to full service performance of assays for infrequent users to meet investigators' individual needs. Ar
Administrative Core coordinates and supports CFAR activities through communications, reporting, accounting ant outreach. A Developmental Core provides support and training for new researchers, which is supplemented by generou., institutional funding.
Strong institutional support is reflected in a nearly $15 million commitment by CWRU and UHC to the CFAR. The CFAF provides added value to the national and international AIDS research effort through its provision of scientific leadership
infrastructure dedicated to AIDS research that provides facilities and resources, including some that are not available a other CFARs, and well-oganized sponsorship of training, education and outreach.
CWRU/UHC CFAR已建立了一项独特的研究计划,具有直接研究,ITUBORCULOSIS,临床/转化研究和培训方面的关键优势。 CWRU和Makerere之间的16年密切合作
乌干达的Iuniversity在坎帕拉有一个有效的HIV研究基础设施。有效的Fogarty AIDS Pntemational培训和研究计划(AIRTP),至少有30位在非洲工作的毕业生也
在乌干达促进了艾滋病毒研究,艾滋病毒护理和预防的增强水平。在克利夫兰和乌干达,通过结核病研究部门,这种主要的合并感染的流行病学,发病机理和治疗的关键研究
CFAR也迟到了。 CWRU研究人员也是领先的新型NCI赞助的化学疗法试验
我/儿童有关的恶性肿瘤在乌干达和肯尼亚。 CWRU/UHC CFAR也开发了最有生产力的
CFAR网络中的IclinicalCores支持了120多个独立的临床和转化研究项目
这段奖项偶然,因为它具有独特的患者护理/研究数据库,这是一个链接的标本存储库
无缝访问患者志愿者和临床样本
RRHE CFAR领导委员会(指导委员会)由7个科学工作组的核心主管和领导者组成,并确保该中心的科学需求和方向与服务需求和资源协调。六
CFAR服务核心均旨在为CWRU调查人员提供在克利夫兰和坎帕拉的用户友好访问最先进的服务和设施。这些核心:乌干达实验室,临床,生物安全,免疫功能,流行病学/生物统计学以及新的分子病毒学和基因表达由高速调查人员领导,并提供了质量服务,包括现场培训和范围从有经验的用户访问仪器的范围内,范围从经验丰富的用户到不及时的分析用户的全面服务,以满足调查员的个人需求。 ar
行政核心坐标并通过通信,报告,会计蚂蚁外展来支持CFAR活动。发展核心为新研究人员提供了支持和培训,该研究人员由机构资金补充。
CWRU和UHC对CFAR的近1500万美元承诺反映了强大的机构支持。 CFAF通过提供科学领导才能为国家和国际艾滋病研究工作增添价值
致力于提供设施和资源的艾滋病研究的基础设施,包括一些其他CFAR,以及培训,教育和外展的良好赞助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN KARN其他文献
JONATHAN KARN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN KARN', 18)}}的其他基金
The role of RNA m6A modification in the regulation of HIV latency and reactivation
RNA m6A 修饰在调节 HIV 潜伏和再激活中的作用
- 批准号:
10600078 - 财政年份:2022
- 资助金额:
$ 12.11万 - 项目类别:
The role of RNA m6A modification in the regulation of HIV latency and reactivation
RNA m6A 修饰在调节 HIV 潜伏和再激活中的作用
- 批准号:
10461499 - 财政年份:2022
- 资助金额:
$ 12.11万 - 项目类别:
Research Support Core B: Primary Cell, Biomimetic, and iPSC-derived Cell Models
研究支持核心 B:原代细胞、仿生和 iPSC 衍生细胞模型
- 批准号:
10304584 - 财政年份:2021
- 资助金额:
$ 12.11万 - 项目类别:
Research Support Core B: Primary Cell, Biomimetic, and iPSC-derived Cell Models
研究支持核心 B:原代细胞、仿生和 iPSC 衍生细胞模型
- 批准号:
10632094 - 财政年份:2021
- 资助金额:
$ 12.11万 - 项目类别:
Control of P-TEFb biogenesis and HIV transcription in primary T-cells
原代 T 细胞中 P-TEFb 生物发生和 HIV 转录的控制
- 批准号:
10158438 - 财政年份:2019
- 资助金额:
$ 12.11万 - 项目类别:
Regulation of HIV latency by microglial-neuronal interactions
小胶质细胞-神经元相互作用对 HIV 潜伏期的调节
- 批准号:
10220927 - 财政年份:2019
- 资助金额:
$ 12.11万 - 项目类别:
Regulation of HIV latency by microglial-neuronal interactions
小胶质细胞-神经元相互作用对 HIV 潜伏期的调节
- 批准号:
10674037 - 财政年份:2019
- 资助金额:
$ 12.11万 - 项目类别:
Control of P-TEFb biogenesis and HIV transcription in primary T-cells
原代 T 细胞中 P-TEFb 生物发生和 HIV 转录的控制
- 批准号:
10403547 - 财政年份:2019
- 资助金额:
$ 12.11万 - 项目类别:
相似国自然基金
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
- 批准号:32302894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
- 批准号:32302893
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
- 批准号:32373024
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
- 批准号:32303043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
International epidemiologic Database to Evaluate AIDS (West Africa) Core
评估艾滋病的国际流行病学数据库(西非)核心
- 批准号:
7684781 - 财政年份:2006
- 资助金额:
$ 12.11万 - 项目类别:
International epidemiologic Database to Evaluate AIDS (West Africa) Core
评估艾滋病的国际流行病学数据库(西非)核心
- 批准号:
7494610 - 财政年份:2006
- 资助金额:
$ 12.11万 - 项目类别:
International epidemiologic Database to Evaluate AIDS (West Africa) Core
评估艾滋病的国际流行病学数据库(西非)核心
- 批准号:
7937068 - 财政年份:2006
- 资助金额:
$ 12.11万 - 项目类别: